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a b s t r a c tStudy Objective: To determine the speciﬁc characteristics of premenstrual syndrome (PMS)/premenstrual dysphoric disorder (PMDD) in
Japanese collegiate athletes, with a focus on their ﬁsh consumption.
Design: Cross-sectional study.
Setting: A university in Osaka, the largest city in western Japan.
Participants and Interventions: The participants were 312 female collegiate students. The study group was composed of 200 students who
were members of sport clubs, and the control (nonathletes) group was composed of 112 members of cultural clubs.
Main Outcome Measures: Premenstrual symptoms and social activities.
Results: The prevalence of moderate to severe PMS and PMDD in the study group was the same as in nonathletes. The prominent feature of
premenstrual symptoms in athletes was that the severities of ‘physical symptoms’ and ‘performance in training or competition’ were much
greater than those of nonathletes (P5 .003 and P5 .002, ManneWhitney U test). There was a greater effect of PMS and PMDD on athletes,
affecting their physical symptoms and performance compared with nonathletes. In terms of dietary habits, ‘ﬁsh or dried ﬁsh’ consumption
was associated with a decreased risk of poor performance in athletes (odds ratio, 0.61; 95% conﬁdence interval, 0.40-0.92).
Conclusion: The results from this study indicate that ﬁsh consumption might be positively associated with the relief of PMS/PMDD-induced
athletic disturbance.
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Premenstrual syndrome (PMS) is a complex collection of
mood, behavioral, and physical changes that are limited to
the premenstrual phase and recover at the start of
menstruation.1 Epidemiologic surveys have shown that the
frequency of premenstrual symptoms is high (80%-90%).2 In
approximately 5% of women, the symptoms are so severe
that they interfere with personal or social relationships.3
The Diagnostic and Statistical Manual of Mental Disorders
(DSM)-IV4 deﬁned such severe PMS as premenstrual
dysphoric disorder (PMDD). In the DSM-IV PMDD was
considered a form of depressive disorder.
In the past 40 years, female athletic participation has
increased, particularly at high school and collegiate levels.5
Many reports have documented that the premenstrual
phase is associated with decreased performance,6,7 but
there are few reports about PMS/PMDD in athletes. Previ-
ously, we reported that PMS and PMDD are common
menstrual problems in female collegiate athletes, and
almost half of athletes perceived a negative effect of pre-
menstrual symptoms on athletic performance.8 Stress
exposure could result in persistent alterations inThe authors indicate no conﬂicts of interest.
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training and competitive anxiety could induce great stress
in athletes.
The precise pathogenic mechanisms of PMS and PMDD
are not yet known. The causes of PMS and PMDD have been
suggested to include hormonal changes, serotonergic
dysfunction, poor dietary habits, stress, and lack of exer-
cise.10 Among these factors, dietary changes or supplements
could be recommended as nonpharmacological medical
approaches. Fish consumption has been identiﬁed as a
protective factor against many diseases, and epidemiolog-
ical studies have shown a strong negative association
between depression and ﬁsh consumption.11,12 Fish is a
major source of omega-3 fatty acids, such as eicosa-
pentaenoic acid and docosahexaenoic acid, and supple-
mentation of omega-3 fatty acids has been shown to be
good for the relief of depression.13 One previous report
showed that omega-3 fatty acids had beneﬁcial effects for
the relief of PMS symptoms,14 but data on the association
between PMS/PMDD and ﬁsh consumption are lacking.
Stress exposure can result in persistent alterations in the
neuroendocrine system and induce PMS/PMDD,9 and
intensive training and competitive anxiety can induce great
stress in athletes. On the basis of these considerations, PMS/
PMDD in athletes could show unique properties.
The aim of this study was to investigate the properties of
PMS/PMDD in Japanese collegiate athletes compared with
nonathlete students, and especially in relation to ﬁsh
consumption.lished by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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The study was carried out in accordance with the prin-
ciples outlined in the Declaration of Helsinki. Our institu-
tional review board at Kinki University approved the study.
Study Population
A school-based cross-sectional survey was conducted in
July 2014 using a sample of 368 Japanese female collegiate
students at Kinki University in Osaka, the largest city in
western Japan. All subjects belonged to authorized univer-
sity sports or cultural clubs. In total, 225 students were
members of sport clubs and 143 students were members of
cultural clubs. All subjects were undergoing intensive
training. We selected students who belonged to cultural
clubs as nonathletes; these students belonged to orchestra,
mandolin, easy listening music, traditional Japanese music,
and drama clubs. We recruited female students who had
regular menstrual cycles (22-35 days) and were able to
provide informed consent. None of the subjects had a pre-
vious diagnosis of a psychological disorder.
Questionnaire
We used the Premenstrual Symptoms Questionnaire
(PSQ), which was developed in our previous study,15 to
screen for premenstrual symptoms. The PSQ translates
DSM-IV criteria into a rating scale with degrees of severity
described in Japanese and is essentially identical to the
Premenstrual Symptoms Screening Tool.16 A translated
summary of the PSQ is shown as Table 1. We divided stu-
dents with premenstrual symptoms into 3 groups: ‘PMDD,’
‘moderate to severe PMS,’ and ‘no/mild PMS’ according to
the criteria reported previously.15,16 In addition to the PSQ,
we asked whether such premenstrual symptoms interfered
with ‘performance in training or competition.’ An additional
question also asked the students to rate the severity as ‘not
at all,’ ‘mild,’ ‘moderate,’ or ‘severe.’ We also collected
additional information about their age, participation inTable 1
Premenstrual Symptoms Questionnaire
(A) “Within the past 3 months, have you experienced the following
premenstrual symptoms starting during the week before menses and
ending a few days after the onset of menses?”
1. ‘Depressed mood’
2. ‘Anxiety or tension’
3. ‘Tearful’
4. ‘Anger or irritability’
5. ‘Decreased interest in work, home, or social activities’
6. ‘Difﬁculty concentrating’
7. ‘Fatigue or lack of energy’
8. ‘Overeating or food cravings’
9. ‘Insomnia or hypersomnia’
10. ‘Feeling overwhelmed’
11. ‘Physical symptoms such as tender breasts, feeling of bloating, headache,
joint or muscle pain, or weight gain’
(B) “Did any premenstrual symptoms interfere with the following activities?”
1. ‘Work efﬁciency or productivity, or home responsibilities’
2. ‘Social life activities’
3. ‘Relationships with coworkers or family’
Rate the severity of premenstrual symptoms as:
‘Not at all’ ‘Mild’ ‘Moderate’ ‘Severe’national or international competition, and whether they
were a regular player or not. Athletes were grouped into 5
groups: ball games, swimming, ﬁghting sports, archery, and
other sports. The other sports group consisted of yacht
racing and triathlon. We asked the students about their
severity of pain during menses with the categories of ‘not at
all,’ ‘mild,’ ‘moderate,’ and ‘severe.’
We collected information on dietary habits during the
past month for seven foods. The foods investigated were,
‘ﬁsh or dried ﬁsh,’ ‘ﬁsh paste,’ ‘squid, octopus, shrimp, or
shellﬁsh,’ ‘chicken,’ ‘pork or beef,’ ‘instant noodles,’ and
‘spaghetti, pasta or Japanese udon noodles.’ The frequency
of food consumption was divided into seven grades: none,
less than once per week, once per week, 2-3 times per
week, 4-6 times per week, once per day, and more than two
times per day. These items were extracted from a brief, self-
administered diet history questionnaire.17
Statistical Analyses
The ManneWhitney U test was applied to test the
difference in prevalence of menstrual pain and each pre-
menstrual symptom between athletes and nonathletes.
Multivariate analysis was applied to analyze factors that
were signiﬁcantly associated with reduced performance in
training or competition. Statistical analysis was performed
using JMP 10.0.2 (SAS, Cary, NC). Data are expressed as
mean  SD. Statistical signiﬁcance was set at P ! .05.
Post hoc power analysis was performed using the
statistical power analysis program G*power3.18
Results
A total of 342 students completed the questionnaire.
Thirty were excluded from the analysis because of incom-
plete data; therefore, we analyzed data from 312 students
aged 18-23 years (average 19.7  1.26 years).
The characteristics of the study population are presented
in Table 2. Considering that half of the athletes participated
in national or international competitions, all of these clubs
have a high ranking in Japanese university sport.
The prevalence of menstrual pain and each premenstrual
symptom is shown in Table 3. The prominent feature of
premenstrual symptoms in athletes was that the severities
of ‘physical symptoms’ and ‘performance in training orTable 2
Characteristics of Study Participants (N 5 312)
Characteristic n (%)
Athletes 200 (100)
Type of sport
High-impact sports 168 (84.0)
Ball games 73 (36.5)
Swimming 18 (9.0)
Fighting sports 72 (36.0)
Triathlon 5 (2.5)
Low-impact sports 32 (16.0)
Archery 28 (14.0)
Yachting 4 (2.0)
Participation in national or international competitions 117 (58.5)
Regular player 118 (59.0)
Nonathletes 112 (100)
Table 3
Prevalence Rates of Menstrual Pain, Premenstrual Symptoms, and Induced Inter-
ference with Work, Usual Activities, or Relationships with Degrees of Severity
among Athletes (n 5 200) and Nonathletes (n 5 112)
Variable Not at All,
n (%)
Mild,
n (%)
Moderate,
n (%)
Severe,
n (%)
P*
Menstrual pain
Athletes 30 (15.0) 79 (39.5) 68 (34.0) 23 (11.5) .403
Nonathletes 15 (13.4) 38 (33.9) 48 (42.9) 11 (9.8)
Premenstrual symptoms
Depressed mood
Athletes 102 (51.0) 45 (22.5) 42 (21.0) 11 (5.5) .145
Nonathletes 46 (41.1) 33 (29.5) 24 (21.4) 9 (8.0)
Anxiety or tension
Athletes 44 (22.0) 80 (40.0) 57 (28.5) 19 (9.5) .612
Nonathletes 22 (19.6) 43 (38.4) 39 (34.8) 8 (7.1)
Tearful
Athletes 98 (49.0) 50 (25.0) 42 (21.0) 10 (5.0) .572
Nonathletes 48 (42.9) 38 (33.9) 19 (17.0) 7 (6.3)
Anger or irritability
Athletes 47 (23.5) 90 (45.0) 46 (23.0) 17 (8.5) .862
Nonathletes 30 (26.8) 40 (35.7) 35 (31.3) 7 (6.2)
Decreased interest in work, home, or social activities
Athletes 104 (52.0) 61 (30.5) 27 (13.5) 8 (4.0) .078
Nonathletes 68 (60.7) 33 (29.5) 8 (7.1) 3 (2.7)
Difﬁculty concentrating
Athletes 88 (44.0) 72 (36.0) 31 (15.5) 9 (4.5) .291
Nonathletes 40 (35.7) 49 (43.7) 19 (17.0) 4 (3.6)
Fatigue or lack of energy
Athletes 56 (28.0) 80 (40.0) 42 (21.0) 22 (11.0) .944
Nonathletes 28 (25.0) 51 (45.5) 24 (21.4) 9 (8.1)
Overeating or food cravings
Athletes 57 (28.5) 73 (36.5) 51 (25.5) 19 (9.5) .168
Nonathletes 44 (39.3) 32 (28.6) 26 (23.2) 10 (8.9)
Insomnia or hypersomnia
Athletes 87 (43.5) 58 (29.0) 40 (20.0) 15 (7.5) .948
Nonathletes 47 (42.0) 35 (31.3) 23 (20.5) 7 (6.3)
Feeling overwhelmed
Athletes 132 (66.0) 45 (22.5) 17 (8.5) 6 (3.0) .160
Nonathletes 64 (57.1) 34 (30.4) 10 (8.9) 4 (3.6)
Physical symptoms
Athletes 49 (24.5) 70 (35.0) 63 (31.5) 18 (9.0) .003
Nonathletes 40 (35.7) 45 (40.2) 21 (18.8) 6 (5.4)
Interference with work, usual activities, or relationships
Work efﬁciency or productivity, home responsibility
Athletes 99 (49.5) 70 (35.0) 30 (15.0) 1 (0.5) .053
Nonathletes 40 (35.7) 54 (48.2) 16 (14.3) 2 (1.8)
Social life activities
Athletes 167 (83.5) 23 (11.5) 9 (4.5) 1 (0.5) !.001
Nonathletes 75 (67.0) 27 (24.1) 7 (6.3) 3 (2.7)
Relationships with coworkers or family
Athletes 148 (74.0) 39 (19.5) 10 (5.0) 3 (1.5) .200
Nonathletes 75 (67.0) 28 (25.0) 8 (7.1) 1 (0.9)
Performance in training or competition
Athletes 113 (56.5) 59 (29.5) 23 (11.5) 5 (2.5) .002
Nonathletes 80 (71.4) 30 (26.8) 1 (0.9) 1 (0.9)
No or Mild
PMS
Moderate to Severe
PMS
PMDD
Severity of PMS/PMDD
Athletes 166 (83.0) 29 (14.5) 5 (2.5) .652
Nonathletes 91 (81.3) 16 (14.3) 5 (4.5)
PMDD, premenstrual dysphoric disorder; PMS, premenstrual syndrome.
* ManneWhitney U test.
Table 4
Multivariate Analysis of Risk Factors for Interference with Performance Because of
Premenstrual Symptoms
Risk Factor OR (95% CI)
Athletes (n 5 200) Nonathletes (n 5 112)
Age 1.06 (0.78-1.44) 0.65 (0.32-1.21)
Dysmenorrhea 1.34 (0.81-2.22) 0.57 (0.19-1.46)
Premenstrual symptoms
Depressed mood 0.81 (0.40-1.62) 0.96 (0.22-3.72)
Anxiety or tension 1.00 (0.46-2.14) 0.88 (0.16-4.43)
Tearful 1.70 (0.84-3.44) 1.11 (0.39-3.33)
Anger or irritability 0.61 (0.31-1.17) 4.01 (1.01-20.6)*
Decreased interest in
work, home, or
social activities
1.07 (0.56-2.04) 2.05 (0.65-7.80)
Difﬁculty concentrating 1.08 (0.53-2.19) 3.07 (0.74-15.5)
Fatigue or lack of energy 1.97 (0.98-4.15) 0.86 (0.20-3.60)
Overeating or food cravings 1.36 (0.85-2.17) 0.35 (0.10-1.00)
Insomnia or hypersomnia 1.57 (0.93-2.66) 0.65 (0.22-1.81)
Feeling overwhelmed 0.66 (0.30-1.39) 1.48 (0.42-5.27)
Physical symptoms 0.81 (0.47-1.36) 1.09 (0.43-2.73)
Induced interference with
work, usual activities,
or relationships
Work efﬁciency or
productivity, home
responsibility
2.24 (1.14-4.49)* 1.98 (0.52-9.22)
Social life activities 1.18 (0.46-3.18) 3.26 (0.96-12.6)
Relationships with
coworkers or family
1.84 (0.79-4.55) 4.98 (1.26-24.6)*
Dietary habits
Fish or dried ﬁsh 0.61 (0.40-0.92)* 0.68 (0.27-16.6)
Fish past 1.07 (0.75-1.54) 0.52 (0.20-1.23)
Squid, octopus,
shrimp, or shellﬁsh
1.14 (0.74-1.78) 1.47 (0.63-3.79)
Chicken 0.86 (0.52-1.39) 1.52 (0.50-4.64)
Pork or beef 1.28 (0.77-2.19) 0.49 (0.13-1.52)
Instant noodle 1.06 (0.79-1.44) 1.28 (0.62-2.85)
Spaghetti, pasta, or udon 1.28 (0.90-1.84) 0.74 (0.28-1.82)
CI, conﬁdence interval; OR, odds ratio.
* P ! .05.
T. Takeda et al. / J Pediatr Adolesc Gynecol 29 (2016) 386e389388competition’ were much higher than those of nonathletes
(P 5 .003 and P 5 .002, ManneWhitney U test). Another
feature in athletes was that the severity of the effect on
‘social life activities’ was much lower than that of non-
athletes (P ! .001, ManneWhitney U test). The rates of
PMDD and moderate to severe PMS in athletes were not
signiﬁcantly higher than those in nonathletes (P 5 .652,
ManneWhitney U test).
Whenwe applied a post hoc power analysis to this study
with a total sample of 312 and an a error of 0.05, the power(1-b) of ‘physical symptoms,’ ‘social life activities,’ and
‘performance in training or competition’ were calculated as
0.825, 0.825, and 0.940, respectively.
The results of multivariate analysis of the factors that
were signiﬁcantly associated with reduced performance in
training or competition are shown in Table 4. ‘Work efﬁ-
ciency or productivity, home responsibility’ showed an
increased risk of poor performance in athletes. However,
‘anger or irritability’ and ‘relationships with coworkers or
family’ showed an increased risk of poor performance in
nonathletes. Regarding dietary habits, the consumption of
‘Fish or dried ﬁsh’ was associated with a decreased risk of
poor performance in athletes.Discussion
Intensive training and competitive anxiety induce great
stress in athletes. Our data showed a high prevalence of
premenstrual symptoms in athletes, but the severity of
PMS/PMDD was the same as that of nonathletes. We
selected students who were members of cultural clubs as
nonathletes. Considering that these clubs are also top-
ranking in their respective ﬁelds, the nonathletes were
also practicing hard every day without a break and suffering
from as much stress as the athletes.
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treatment for PMS/PMDD,19,20 but our data showed that the
severity of symptoms was worse in athletes compared with
nonathletes. A possible explanation for this discrepancy is
that the athletes in this study were all high-ranking in
Japanese university sport, as shown in Table 2, so they
might suffer substantial stress from their intensive training.
Too much exercise could induce great stress and cancel the
beneﬁcial effect of exercise for PMS/PMDD.
Our data showed that the prevalence of ‘physical symp-
toms’ in athletes was much higher than in nonathletes.
Water retention symptoms, especially edema, might disturb
the motion of athletes. Breast tenderness will also be
exacerbated by athletic behavior and they feel much more
load than nonathletes. Our data also showed that the
prevalence of effects on ‘performance in training or
competition’ was much higher than in nonathletes. Athletic
performance is regulated in a multifaceted way: cardio-
pulmonary, metabolic, endocrinological, neurological, and
psychological factors are all closely associated with each
other and deﬁne athletic ability.21 Considering that PMS/
PMDD is a complex collection of mood, behavioral, and
physical changes, it could be more likely that athletes are
much more sensitive than nonathletes in their
performance.
Multivariate analysis revealed that consumption of ‘ﬁsh
or dried ﬁsh’ was associated with a decreased risk of poor
performance only in athletes. In general, athletes are
expected to have healthy lifestyles compared with non-
athletes. The lifestyle background of athletes is much more
homogeneous than nonathletes. For this reason, dietary
factors might have a stronger effect on athletes than
nonathletes.
High levels of ﬁsh consumption could help to alleviate
PMS/PMDD-induced disturbances in athletic performance
by 2 mechanisms. First, ﬁsh consumption might be bene-
ﬁcial for PMS/PMDD. One previous report showed that
omega-3 fatty acids have beneﬁcial effects for the relief of
PMS symptoms.14 Second, ﬁsh consumption might be
beneﬁcial for improving athletic performance. Omega-3
fatty acids supplementation for the improvement of ath-
letic performance has been studied extensively.21 Potential
beneﬁcial effects of omega-3 fatty acids include ergogenic
aids, decreasing fatigue, and improvement of neuromotor
function.
Our study had several limitations. The main limitation
was that all of our data were on the basis of self-report;
therefore, the study was susceptible to recall bias. The
second limitationwas that this study was conducted only in
Japan, and Japanese people are well known to have high
levels of ﬁsh consumption.11 It is likely that our data might
not be applicable to other countries. However, the Japanese
Fisheries White Paper says the ﬁsh consumption per annum
has decreased by two-thirds over the past 2 decades and
this tendency has been especially prominent in younger
people. The third limitation was that we have checked the
consumption frequency of only a limited range of foods, so
we could not assess total omega-3 fatty acids intake in this
study. We could also not exclude the inﬂuence of non-
reported food items. In view of this limitation, we are nowexamining the frequency of food consumption in more
detail in our next study.
Research on female athletes has focused on menstrual
dysfunction, such as amenorrhea and oligomenorrhea,5 so
ovulation-induced PMS/PMDD symptoms have been
generally overlooked. Judging from our previous data as
well as the present study, almost half of the athletes
perceived a negative effect of PMS/PMDD symptoms on
their performance, and it is, therefore, important to pay
attention to PMS/PMDD. Dietary interventions, such as ﬁsh
consumption, might be the safest treatment strategy for
PMS/PMDD. Further research including a placebo-control
study is warranted to conﬁrm the effect of this noninva-
sive treatment.Acknowledgments
This work was supported, in part, by grants from JSPS
KAKENHI Grant Number 15K01636, Tokyo, Japan, and
Research Promotion and Practical Use for Women's Health
Grant Number 15gk0210009h0101, AMED, Tokyo, Japan.References
1. Yonkers KA, O'Brien PM, Eriksson E: Premenstrual syndrome. Lancet 2008; 371:
1200
2. Angst J, Sellaro R, Merikangas KR, et al: The epidemiology of perimenstrual
psychological symptoms. Acta Psychiatr Scand 2001; 104:110
3. Dimmock PW, Wyatt KM, Jones PW, et al: Efﬁcacy of selective
serotonin-reuptake inhibitors in premenstrual syndrome: a systematic re-
view. Lancet 2000; 356:1131
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental
Disorders: DSM-5. Arlington, American Psychiatric Association, 2013
5. Javed A, Tebben PJ, Fischer PR, et al: Female athlete triad and its components:
toward improved screening and management. Mayo Clin Proc 2013; 88:996
6. Eston RG: The regular menstrual cycle and athletic performance. Sports Med
1984; 1:431
7. Constantini NW, Dubnov G, Lebrun CM: The menstrual cycle and sport
performance. Clin Sports Med 2005; 24:e51. xiii.
8. Takeda T, Imoto Y, Nagasawa H, et al: Premenstrual syndrome and
premenstrual dysphoric disorder in Japanese collegiate athletes. J Pediatr
Adolesc Gynecol 2015; 28:215
9. Heim C, Newport DJ, Heit S, et al: Pituitary-adrenal and autonomic responses to
stress in women after sexual and physical abuse in childhood. JAMA 2000; 284:
592
10. Grady-Weliky TA: Clinical practice. Premenstrual dysphoric disorder. N Engl J
Med 2003; 348:433
11. Hibbeln JR: Fish consumption and major depression. Lancet 1998; 351:1213
12. Smith KJ, Sanderson K, McNaughton SA, et al: Longitudinal associations
between ﬁsh consumption and depression in young adults. Am J Epidemiol
2014; 179:1228
13. Appleton KM, Rogers PJ, Ness AR: Updated systematic review and meta-analysis
of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood.
Am J Clin Nutr 2010; 91:757
14. Sohrabi N, Kashanian M, Ghafoori SS, et al: Evaluation of the effect of omega-3
fatty acids in the treatment of premenstrual syndrome: “a pilot trial”.
Complement Ther Med 2013; 21:141
15. Takeda T, Tasaka K, Sakata M, et al: Prevalence of premenstrual syndrome and
premenstrual dysphoric disorder in Japanese women. Arch Women Ment
Health 2006; 9:209
16. Steiner M, Macdougall M, Brown E: The premenstrual symptoms screening tool
(PSST) for clinicians. Arch Women Ment Health 2003; 6:203
17. Kobayashi S, Honda S, Murakami K, et al: Both comprehensive and brief
self-administered diet history questionnaires satisfactorily rank nutrient in-
takes in Japanese adults. J Epidemiol 2012; 22:151
18. Faul F, Erdfelder E, Lang AG, et al: G*Power 3: a ﬂexible statistical power
analysis program for the social, behavioral, and biomedical sciences. Behav
Res Methods 2007; 39:175
19. Vishnupriya R, Rajarajeswaram P: Effects of aerobic exercise at different
intensities in pre menstrual syndrome. J Obstet Gynecol India 2011; 61:675
20. Daley A: Exercise and premenstrual symptomatology: a comprehensive review.
J Women Health (Larchmt) 2009; 18:895
21. Mickleborough TD: Omega-3 polyunsaturated fatty acids in physical
performance optimization. Int J Sport Nutr Exerc Metab 2013; 23:83
